Increased Microvessel and Arteriole Density in the Contracted Side of the Relapsed Clubfoot.
Journal
Journal of pediatric orthopedics
ISSN: 1539-2570
Titre abrégé: J Pediatr Orthop
Pays: United States
ID NLM: 8109053
Informations de publication
Date de publication:
Historique:
pubmed:
8
5
2020
medline:
9
3
2021
entrez:
8
5
2020
Statut:
ppublish
Résumé
Clubfoot deformity (pes equinovarus) is one of the most common birth defects, and its etiology is still unknown. Initial clubfoot treatment is based on the Ponseti method throughout most of the world. Despite the effectiveness of this therapy, clubfoot may relapse. Recent studies confirm the theory of active fibrotic remodeling processes in the extracellular matrix of the affected tissue. The aim of this study was to clarify whether relapses in clubfoot therapy are associated with altered angiogenesis and to suggest possible regulatory pathways of this pathologic process. We compared microvessel density, arteriole density, and concentration of angioproliferative-related proteins found between tissues in the contracted, that is, the medial side (M-side), and noncontracted, that is, the lateral side (L-side) of the relapsed clubfeet. Tissue samples from 10 patients were analyzed. Histopathologic analysis consisted of immunohistochemistry and image analysis. Real-time polymerase chain reaction was used to study mRNA expression. An increase in microvessel and arteriole density was noted in contracted, relapsed clubfoot tissue. This was accompanied by a significant increase in the levels of the vascular endothelial growth factor, vascular endothelial growth factor receptor 2, β catenin and active β catenin. Vascular endothelial growth factor, vascular endothelial growth factor receptor 2, and CD31 overexpression was also seen with mRNA analysis. Increased microvessel and arteriole density in the contracted side of the relapsed clubfoot was noted. These processes are mediated by specific proangiogenic proteins that are overexpressed in the contracted tissue. These findings contribute to the etiology and the development of relapses in the treatment of clubfoot. Level II-analytical and prospective.
Sections du résumé
BACKGROUND
BACKGROUND
Clubfoot deformity (pes equinovarus) is one of the most common birth defects, and its etiology is still unknown. Initial clubfoot treatment is based on the Ponseti method throughout most of the world. Despite the effectiveness of this therapy, clubfoot may relapse. Recent studies confirm the theory of active fibrotic remodeling processes in the extracellular matrix of the affected tissue. The aim of this study was to clarify whether relapses in clubfoot therapy are associated with altered angiogenesis and to suggest possible regulatory pathways of this pathologic process.
METHODS
METHODS
We compared microvessel density, arteriole density, and concentration of angioproliferative-related proteins found between tissues in the contracted, that is, the medial side (M-side), and noncontracted, that is, the lateral side (L-side) of the relapsed clubfeet. Tissue samples from 10 patients were analyzed. Histopathologic analysis consisted of immunohistochemistry and image analysis. Real-time polymerase chain reaction was used to study mRNA expression.
RESULTS
RESULTS
An increase in microvessel and arteriole density was noted in contracted, relapsed clubfoot tissue. This was accompanied by a significant increase in the levels of the vascular endothelial growth factor, vascular endothelial growth factor receptor 2, β catenin and active β catenin. Vascular endothelial growth factor, vascular endothelial growth factor receptor 2, and CD31 overexpression was also seen with mRNA analysis.
CONCLUSIONS
CONCLUSIONS
Increased microvessel and arteriole density in the contracted side of the relapsed clubfoot was noted. These processes are mediated by specific proangiogenic proteins that are overexpressed in the contracted tissue. These findings contribute to the etiology and the development of relapses in the treatment of clubfoot.
LEVEL OF EVIDENCE
METHODS
Level II-analytical and prospective.
Identifiants
pubmed: 32379245
doi: 10.1097/BPO.0000000000001563
pii: 01241398-202011000-00017
doi:
Substances chimiques
CTNNB1 protein, human
0
VEGFA protein, human
0
Vascular Endothelial Growth Factor A
0
beta Catenin
0
KDR protein, human
EC 2.7.10.1
Vascular Endothelial Growth Factor Receptor-2
EC 2.7.10.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
592-596Commentaires et corrections
Type : CommentIn
Références
Poon R, Li C, Alman BA. Beta-catenin mediates soft tissue contracture in clubfoot. Clin Orthop Relat Res. 2009;467:1180–1185.
Pavone V, Chisari E, Vescio A, et al. The etiology of idiopathic congenital talipes equinovarus: a systematic review. J Orthop Surg Res. 2018;13:206–216.
Dobbs MB, Gurnett CA. Update on clubfoot: etiology and treatment. Clin Orthop Relat Res. 2009;467:1146–1153.
Shabtai L, Specht SC, Herzenberg JE. Worldwide spread of the Ponseti method for clubfoot. World J Orthop. 2014;5:585–590.
Ostadal M, Liskova J, Hadraba D, et al. Possible pathogenetic mechanisms and new therapeutic approaches of pes equinovarus. Physiol Res. 2017;66:403–410.
Eckhardt A, Novotny T, Doubkova M, et al. Novel contribution to clubfoot pathogenesis: the possible role of extracellular matrix proteins. J Orthop Res. 2019;37:769–778.
Kerling A, Stoltenburg-Didinger G, Grams L, et al. The congenital clubfoot—immunohistological analysis of the extracellular matrix. Orthop Res Rev. 2018;10:55–62.
Holzer LA, Cor A, Pfandlsteiner G, et al. Expression of VEGF, its receptors, and HIF-1alpha in Dupuytren’s disease. Acta Orthop. 2013;84:420–425.
Ponseti IV. Treatment of congenital club foot. J Bone Joint Surg Am. 1992;74:448–454.
Thelin MA, Bartolini B, Axelsson J, et al. Biological functions of iduronic acid in chondroitin/dermatan sulfate. FEBS J. 2013;280:2431–2446.
Xu Q, Wu N, Cui L, et al. The next hotspot in skeletal research? J Genet Genomics. 2017;44:335–342.
Maffulli N, Capasso G, Testa V, et al. Histochemistry of the triceps surae muscle in idiopathic congenital clubfoot. Foot Ankle. 1992;13:80–84.
Ponseti IV. Relapsing clubfoot: causes, prevention, and treatment. Iowa Orthop J. 2002;22:55–56.
Radler C. The Ponseti method for the treatment of congenital club foot: review of the current literature and treatment recommendations. Int Orthop. 2013;37:1747–1753.
Laaveg SJ, Ponseti IV. Long-term results of treatment of congenital club foot. J Bone Joint Surg Am. 1980;62:23–31.
Alves C, Escalda C, Fernandes P, et al. Ponseti method: does age at the beginning of treatment make a difference? Clin Orthop Relat Res. 2009;467:1271–1277.
Paulsen-Miller M, Dolan LA, Stineman A, et al. Understanding the educational needs for parents of children with clubfoot. Orthop Nurs. 2011;30:273–278; quiz 9–80.
Nishisho T, Yukata K, Matsui Y, et al. Angiogenesis and myogenesis in mouse tibialis anterior muscles during distraction osteogenesis: VEGF, its receptors, and myogenin genes expression. J Orthop Res. 2012;30:1767–1773.
Li C, Nguyen Q, Cole WG, et al. Potential treatment for clubfeet based on growth factor blockade. J Pediatr Orthop. 2001;21:372–377.
Schluter A, Weller P, Kanaan O, et al. CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma. BMC Cancer. 2018;18:272–279.
Folkman J. Angiogenesis. Ann Rev Med. 2006;57:1–18.
Rehman S, Goodacre R, Day PJ, et al. Dupuytren’s: a systems biology disease. Arthritis Res Ther. 2011;13:238–249.
Marien KM, Croons V, Waumans Y, et al. Development and validation of a histological method to measure microvessel density in whole-slide images of cancer tissue. PLoS One. 2016;11:e0161496.
Shiraki T, Aoyama T, Yokoyama C, et al. LOX-1 plays an important role in ischemia-induced angiogenesis of limbs. PLoS One. 2014;9:e114542.
Barratt SL, Flower VA, Pauling JD, et al. VEGF (vascular endothelial growth factor) and fibrotic lung disease. Int J Mol Sci. 2018;19:1269–1286.
Lam AP, Gottardi CJ. Beta-catenin signaling: a novel mediator of fibrosis and potential therapeutic target. Curr Opin Rheumatol. 2011;23:562–567.
Kim KI, Cho HJ, Hahn JY, et al. Beta-catenin overexpression augments angiogenesis and skeletal muscle regeneration through dual mechanism of vascular endothelial growth factor-mediated endothelial cell proliferation and progenitor cell mobilization. Arterioscler Thromb Vasc Biol. 2006;26:91–98.
Cao H, Wang C, Chen X, et al. Inhibition of Wnt/beta-catenin signaling suppresses myofibroblast differentiation of lung resident mesenchymal stem cells and pulmonary fibrosis. Sci Rep. 2018;8:13644–13657.